Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Alcoa Corporation (NYSE: AA) (“Alcoa”) on behalf of the company’s investors. Since March 2022,...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Compass Minerals International, Inc. (NYSE: CMP) (“Compass”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Avidity Biosciences, Inc. (NASDAQ: RNA) (“Avidity”) on behalf of the company’s investors. Since...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating AnaptysBio, Inc. (NASDAQ: ANAB) (“AnaptysBio”) on behalf of the company’s investors. Since...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Dave Inc. (NASDAQ: DAVE) (“Dave”) on behalf of the company’s investors. Since January 2023,...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) (“Day One”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Luminar Technologies, Inc. (NASDAQ: LAZR) on behalf of the company’s investors. Since July 2023,...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Nurix Therapeutics, Inc. (NASDAQ: NRIX) (“Nurix”) on behalf of the company’s investors. Since July...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Prelude Therapeutics Incorporated (NASDAQ: PRLD) (“Prelude”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Stoke Therapeutics, Inc. (NASDAQ: STOK) (“Stoke”) on behalf of the company’s investors. Since...